Trelegy is projected to reach a $50 million ... which we believe can be addressed with a targeted commercial effort. Approximately 40,000 patients with MSA in the United States suffer from ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for COPD. This article covers topics such as side effects, dosage ...

As reported by GSK, Trelegy sales increased 17% in the quarter ... which we believe can be addressed with a targeted commercial effort. Approximately 40,000 patients with MSA in the United States ...

Commercial real estate investing offers an attractive avenue for those looking to diversify their portfolios with income-producing assets. Unlike residential real estate, commercial properties ...

Trelegy has also been filed for approval in ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy.

driven by strong performance particularly from Trelegy, Evrysdi, the cystic fibrosis franchise and Tremfya. Portfolio Receipts increased 15% to $735 million. Strengthened portfolio by adding ...

Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

The author and editors take ultimate responsibility for the content. Commercial real estate (CRE) is an appealing investment class because of its consistent returns, passive income, and growth ...

Although pressure for decarbonization remains unrelenting, this investment approach has clear limitations for commercial aviation – the business of flying aircraft with more than 100 seats.

Are you a print subscriber? Activate your account. 1 hour 46 min ago By Tim Nudd - 1 hour 48 min ago 3 hours 22 min ago By Ad Age Studio 30 - 4 hours 12 min ago By Ian Baer - 7 hours 21 min ago By ...